Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial.
Lancet Oncol
; 22(6): 824-835, 2021 06.
Article
in En
| MEDLINE
| ID: mdl-34015311
Full text:
1
Collection:
01-internacional
Health context:
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
B7-H1 Antigen
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Lancet Oncol
Year:
2021
Document type:
Article